课题基金 / 基金详情

Harvard-wide Program on Antibiotic Resistance

Harvard-wide Program on Antibiotic Resistance
哈佛大学抗生素耐药性计划
批准号:
7695271
负责人:
Michael S Gilmore
金额:
$131.59万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-01 至 2010-06-30

项目摘要

项目成果

Michael S Gilmore的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Harvard-wide Program on Antibiotic Resistance (HPAR) represents a tightly knit set of collaborative research projects to address one of the leading public health issues in the US -- the spread of antibiotic resistant Staphylococcus aureus as a leading cause of serious infection in the community as well as in ran hospitals. Advanced by a cohesive, multi-disciplinary group of clinical, basic and translational scientists, the theme of this Program Project proposal is to "Derive new approaches for combating MRSA infection, and limiting the development and spread of antibiotic resistance." The expertise of this team ranges from high throughput screening/follow up chemistry, biochemistry, molecular biology/genetics, and molecular pathogenesis to clinical microbiology. The investigators are all among leaders in their respective fields, and bring the perspectives and assets of institutions spanning Harvard University Massachusetts General Hospital, Harvard Medical School, Harvard College, and Schepens Eye Research Institute - to bear. The goal of this Program Project is to capitalize on multi-disciplinary perspectives, =�. and to take both hypothesis driven and discovery approaches, to advance a better understanding of the development (Subproject 1: Hooper) and spread (Subproject 2: Gilmore) of antibiotic resistance in S. aureus; and to identify novel compounds, targets and pathways to compromise the microbe in its interaction with the host (Subproject 3: walker; Subproject 4: Ausubel/Mylonakis [both in collaboration with Hooper and Gilmore]). The entire project is held together, with each project being leveraged by the others, by the Administrative Core (Core A), which will be led by a P1 with considerable administrative experience. The HPAR is specifically designed to synergize and leverage internal and external initiatives, including the Harvard-wide Microbial sciences Initiative and the Catalyst Clinical and Translational Science Center, and the NIAID NARSA program. FD' 7"o vii o'". `-�
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Role of Enterococcus Unique Hypothetical EF1909 in Intrinsic β-lactam Resistance
The Role of Enterococcus Unique Hypothetical EF1909 in Intrinsic β-lactam Resistance
Determinants of Ocular Surface Biogeography
Determinants of Ocular Surface Biogeography
国内基金
海外基金
基于慧眼-HXMT宽能段观测的X射线吸积脉冲星磁场研究
  • 批准号:
    12373051
  • 项目类别:
    面上项目
  • 资助金额:
    55.00万元
  • 批准年份:
    2023
  • 负责人:
    侯贤
  • 依托单位:
多层次纳米叠层块体复合材料的仿生设计、制备及宽温域增韧研究
  • 批准号:
    51973054
  • 项目类别:
    面上项目
  • 资助金额:
    60.0万元
  • 批准年份:
    2019
  • 负责人:
    王建锋
  • 依托单位:
CFHTLS-Wide和CFHTLS-Stripe82观测的弱引力透镜星系团巡天
  • 批准号:
    11103011
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    25.0万元
  • 批准年份:
    2011
  • 负责人:
    陕欢源
  • 依托单位:
精神分裂症全基因组关联研究的通路分析及验证
  • 批准号:
    81071087
  • 项目类别:
    面上项目
  • 资助金额:
    35.0万元
  • 批准年份:
    2010
  • 负责人:
    岳伟华
  • 依托单位: